Standardized and automated solid-phase extraction procedures for high-throughput proteomics of body fluids

Journal of Proteomics

Volumn 77, Issue , 2012, Pages 144-153

  Bladergroen, Marco R ^a   Derks, Rico J E ^a   Nicolardi, Simone ^a   de Visser, Bram ^a   van Berloo, Sander ^a   van der Burgt, Yuri E M ^a   Deelder, André M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

High throughput sample preparation; Mass spectrometry based proteomics; Protein profiling; Solid phase extraction

Indexed keywords

ANALYTICAL EQUIPMENT; ARTICLE; AUTOMATION; BLOOD SAMPLING; BODY FLUID; CONTROLLED STUDY; HIGH THROUGHPUT SCREENING; HUMAN; INTERMETHOD COMPARISON; MAGNETISM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEOMICS; ROBOTICS; SOLID PHASE EXTRACTION; STANDARDIZATION;

BLOOD PROTEINS; FEMALE; HUMANS; MALE; PLASMA; PROTEOMICS; ROBOTICS;

EID: 84870388699     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.07.023     Document Type: Article

References (27)

1. Nilsson T., Mann M., Aebersold R., Yates J.R., Bairoch A., Bergeron J.J. Mass spectrometry in high-throughput proteomics: ready for the big time. Nat Methods 2010, 7:681-685.
2. Brunner E., Ahrens C.H., Mohanty S., Baetschmann H., Loevenich S., Potthast F., et al. A high-quality catalog of the Drosophila melanogaster proteome. Nat Biotechnol 2007, 25:576-583.
3. Nedelkov D., Kiernan U.A., Niederkofler E.E., Tubbs K.A., Nelson R.W. Investigating diversity in human plasma proteins. Proc Natl Acad Sci U S A 2005, 102:10852-10857.
4. Anderson N.L., Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1:845-867.
5. Domon B., Aebersold R. Mass spectrometry and protein analysis. Science 2006, 312:212-217.
6. Beretta L. Proteomics from the clinical perspective: many hopes and much debate. Nat Methods 2007, 4:785-786.
7. Jacobs J.M., Adkins J.N., Qian W.J., Liu T., Shen Y., Camp D.G., et al. Utilizing human blood plasma for proteomic biomarker discovery. J Proteome Res 2005, 4:1073-1085.
8. Washburn M.P., Wolters D., Yates J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001, 19:242-247.
9. Mitchell P. Proteomics retrenches. Nat Biotechnol 2010, 28:665-670.
10. Surinova S., Schiess R., Huttenhain R., Cerciello F., Wollscheid B., Aebersold R. On the development of plasma protein biomarkers. J Proteome Res 2011, 10:5-16.
11. Anderson N.L. Counting the proteins in plasma. Clin Chem 2010, 56:1775-1776.
12. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature 2003, 422:198-207.
13. Pinkse M.W., Uitto P.M., Hilhorst M.J., Ooms B., Heck A.J. Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS and titanium oxide precolumns. Anal Chem 2004, 76:3935-3943.
14. Wuhrer M., Koeleman C.A., Hokke C.H., Deelder A.M. Protein glycosylation analyzed by normal-phase nano-liquid chromatography-mass spectrometry of glycopeptides. Anal Chem 2005, 77:886-894.
15. Albrethsen J. The first decade of MALDI protein profiling: a lesson in translational biomarker research. J Proteomics 2011, 74:765-773.
16. Nicolardi S., Palmblad M., Hensbergen P.J., Tollenaar R.A., Deelder A.M., van der Burgt Y.E. Precision profiling and identification of human serum peptides using Fourier transform ion cyclotron resonance mass spectrometry. Rapid Commun Mass Spectrom 2011, 25:3457-3463.
17. Alagaratnam S., Mertens B.J., Dalebout J.C., Deelder A.M., van Ommen G.J., den Dunnen J.T., et al. Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy. Proteomics 2008, 8:1552-1563.
18. Nicolardi S., Palmblad M., Dalebout H., Bladergroen M., Tollenaar R.A., Deelder A.M., et al. Quality control based on isotopic distributions for high-throughput MALDI-TOF and MALDI-FTICR serum peptide profiling. J Am Soc Mass Spectrom 2010, 21:1515-1525.
19. Huijbers A., Velstra B., Dekker T.J., Mesker W.E., van der Burgt Y.E., Mertens B.J., et al. Proteomic serum biomarkers and their potential application in cancer screening programs. Int J Mol Sci 2010, 11:4175-4193.
20. Huijbers A., Mesker W., Velstra B., van Der Burgt Y., Mertens B., Deelder A., et al. Early detection of colorectal cancer using mass spectrometry based serum protein profiling. Ann Oncol 2010, 21:209.
21. Velstra B., Mesker W.E., van der Burgt Y.E.M., Mertens B.J., Deelder A.M., Tollenaar R.A.E.M. Mass spectrometry based serum protein profiling for the early detection of breast cancer: taking the steps towards clinical implementation. Br J Surg 2010, 97:S5.
22. Mertens B.J.A., van der Burgt Y.E.M., Velstra B., Mesker W.E., Tollenaar R.A.E.M., Deelder A.M. On the use of double cross-validation for the combination of proteomic mass spectral data for enhanced diagnosis and prediction. Stat Probab Lett 2011, 81:759-766.
23. Nadarajah V.D., Mertens B.J.A., Dalebout H., Bladergroen M.R., Alagaratnam S., Garrood P., et al. Serum peptide profiles of duchenne muscular dystrophy (DMD) patients evaluated using data handling strategies for high resolution content. J Proteomics Bioinform 2012, 4:96-103.
24. Tiss A., Smith C., Menon U., Jacobs I., Timms J.F., Cramer R. A well-characterised peak identification list of MALDI MS profile peaks for human blood serum. Proteomics 2010, 10:3388-3392.
25. Lim M.D., Dickherber A., Compton C.C. Before you analyze a human specimen, think quality, variability, and bias. Anal Chem 2011, 83:8-13.
26. McDonnell L.A., van Remoortere A., van Zeijl R.J., Dalebout H., Bladergroen M.R., Deelder A.M. Automated imaging MS: toward high throughput imaging mass spectrometry. J Proteomics 2010, 73:1279-1282.
27. Palmblad M., van der Burgt Y.E., Mostovenko E., Dalebout H., Deelder A.M. A novel mass spectrometry cluster for high-throughput quantitative proteomics. J Am Soc Mass Spectrom 2010, 21:1002-1011.